(Q46470367)

22 December 2017

title

Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates (English)

1 reference

22 December 2017

0 references

11

1 reference

22 December 2017

Stefano Zanotti

15

object named as

Stefano Zanotti

0 references

Ian R Sanderson

object named as

Ian Sanderson

13

0 references

author name string

Francisco A Sylvester

1

1 reference

22 December 2017

Catherine M Gordon

2

1 reference

22 December 2017

Meena Thayu

3

1 reference

22 December 2017

Jon M Burnham

4

1 reference

22 December 2017

Lee A Denson

5

1 reference

22 December 2017

Jonah Essers

6

1 reference

22 December 2017

Serge Ferrari

7

1 reference

22 December 2017

Neera Gupta

8

1 reference

22 December 2017

Martin Hewison

9

1 reference

22 December 2017

Sibylle Koletzko

10

1 reference

22 December 2017

Helen Pappa

12

1 reference

22 December 2017

Leanne Ward

14

1 reference

22 December 2017

Stefano Zanotti

15

1 reference

22 December 2017

publication date

1 December 2013

1 reference

22 December 2017

Inflammatory Bowel Diseases

published in

1 reference

22 December 2017

volume

19

1 reference

22 December 2017

issue

13

1 reference

22 December 2017

page(s)

2919-2926

1 reference

22 December 2017

Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Growth and clinical course of children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

The vitamin D receptor is required for iNKT cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Vitamin D controls T cell antigen receptor signaling and activation of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Skeletal health of children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Vitamin D supplementation in the pediatric rheumatology clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

New developments in osteoimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Osteoblast lineage-specific effects of notch activation in the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Growth factor control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Notch regulation of bone development and remodeling and related skeletal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Matrix-embedded cells control osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Influence of muscle strength on bone strength during childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Normative data for iliac bone histomorphometry in growing children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Long-term development of bone geometry and muscle in pediatric inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Risk factors for initial surgery in pediatric patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Gender differences in presentation and course of disease in pediatric patients with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E3182A5A004

10.1097/MIB.0B013E3182A5A004

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017